Results 61 to 70 of about 11,412 (211)

Impella Versus Intra‐Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO ...
Ilhwan Yeo, Rachel Axman, Daniel Y. Lu, Dmitriy N. Feldman, Jim W. Cheung, Robert M. Minutello, Maria G. Karas, Erin M. Iannacone, Ankur Srivastava, Natalia I. Girardi, Yoshifumi Naka, Shing‐Chiu Wong, Luke K. Kim   +12 more
doaj   +1 more source

Applying DanGer Shock Eligibility Criteria to a Real‐World Cohort of Cardiogenic Shock Patients

Catheterization and Cardiovascular Interventions, Volume 106, Issue 7, Page 3617-3627, December 1, 2025.
ABSTRACT Background The DanGer Shock trial investigated the effects of adding a microaxial flow pump to guideline‐recommended therapy in patients with ST‐elevation myocardial infarction (STEMI)‐related cardiogenic shock (CS), finding a lower all‐cause mortality at 180 days in the intervention group.
Raffaela Miriam Planka, Lukas Herold, Theresa Glantschnig, Gudrun Sommer, Jonathan Pavek, Stefan Hatzl, Nicolas Verheyen, Christoph Strohhofer, Johannes Gollmer, Ewald Kolesnik, Martin Benedikt, Markus Wallner, Andreas Zirlik, Gabor Toth‐Gayor, Dirk von Lewinski   +14 more
wiley   +1 more source

Rare Intraoperative Left Coronary Artery Dissection in Acute Type A Aortic Dissection: VA‐ECMO‐Assisted Coronary Artery Bypass Grafting

Clinical Case Reports, Volume 13, Issue 12, December 2025.
We experienced a case of intraoperative coronary artery dissection that became apparent during weaning from cardiopulmonary bypass. This case demonstrates the successful management of cardiogenic shock secondary to intraoperative left coronary artery dissection using venoarterial extracorporeal membrane oxygenation for beating‐heart coronary artery ...
Yuta Nakamura, Keita Saku, Suzu Homma, Noriaki Moriyama, Takashi Ota   +4 more
wiley   +1 more source

Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure [PDF]

, 2014
BACKGROUND: The purpose of this prospective study was to evaluate the effects and functional outcome of central extracorporeal life support (ECLS) with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure ...
Alexander Weymann, Andre Ruediger Simon, Anton Sabashnikov, Arjang Ruhparwar, Aron Frederik Popov, Bastian Schmack, Christopher T Bowles, Jens Roggenbach, Markus Verch, Matthias Karck, Philipp Raake, Rawa Arif, Ursula Tochtermann   +12 more
core   +1 more source

Impact of standardized team‐based care on cardiogenic shock outcomes over time

ESC Heart Failure, Volume 12, Issue 6, Page 4379-4390, December 2025.
This contemporary North American cardiogenic shock (CS) registry aimed to investigate the influence of team‐based care on outcomes over a six‐year period of time following implementation of standardized protocols. Despite a two‐fold increase in the number of CS patients and changes in presentation and management strategies, no differences in in ...
Behnam N. Tehrani, Carolyn M. Rosner, Adetokunbo Fadahunsi, Kimberly Barker, Wayne B. Batchelor, Vanessa Blumer, Lindsay Clevenger, Shashank Desai, Michelle Ferri, Evan Franke, Jamie Kennedy, Christopher King, Edward Howard, Iyad Isseh, Seiyon Ben Lee, Aditya Mehta, Mitchell Psotka, Ramesh Singh, Shashank S. Sinha, Matthew W. Sherwood, Daniel Tang, Megan Terek, Alexander G. Truesdell, Ilan Vavilin, Christopher M. O'Connor   +24 more
wiley   +1 more source

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients

Frontiers in Cardiovascular Medicine, 2020
Background: In-hospital mortality in acute myocardial infarction-related cardiogenic shock (AMI-CS) remains high. The only adequately powered randomized trial showed no benefit of routine use of the intra-aortic balloon pump in AMI-CS.
Andreas Schäfer, Nikos Werner, Nikos Werner, Daniel Burkhoff, Jan-Thorben Sieweke, Andreas Zietzer, Maryna Masyuk, Nanna Louise Junker Udesen, Ralf Westenfeld, Jacob Eifer Møller   +9 more
doaj   +1 more source

Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial [PDF]

, 2015
Background: The role of epicardial substrate ablation of ventricular tachycardia (VT) as a first-line approach in patients with ischemic heart disease is not clearly defined.
Geller, L. (Laszlo), Hendriks, A.A. (Astrid), Kardos, A. (Attila), Khan, M. (Muchtiar), Szili-Török, T. (Tamás), Theuns, D.A.M.J. (Dominic), Vries, L.J. (Lennart) de, Wijchers, S.A. (Sip A.), Yap, S.C. (Sing-Chien)   +8 more
core   +4 more sources

Percutaneous repositioning of Impella RP: the Snare–Manoeuvre–Prolapse technique—a case report [PDF]

, 2022
Sandeep M. Patel
openalex   +1 more source

Prognostic Value of Antiarrhythmic Drug Suppression of Electrical Storm Prior to Ventricular Tachycardia Ablation

Journal of Cardiovascular Electrophysiology, Volume 36, Issue 12, Page 3310-3320, December 2025.
Kaplan Meir survival curves comparing the elective and urgent groups from time of ablation. Top Left: Long‐term survival. Top Right: VT‐free survival. Bottom Left: ES‐free survival. Bottom Right: Repeat ablation‐free survival. Long term survival was significantly improved in the elective group.
Rafik Issa, Osama El‐Sayed, Mohammed Al‐Sadawi, Muazzum Shah, Kelly Arps, Amrish Deshmukh, Michael Ghannam, Rakesh Latchamsetty, Krit Jongnarangsin, Thomas Crawford, Aman Chugh, Hakan Oral, Fred Morady, Frank Bogun, Jackson J. Liang   +14 more
wiley   +1 more source

Surgically implanted endovascular, microaxial left ventricular assist device: A single institution studyCentral MessagePerspective

JTCVS Techniques
Objective: The Impella 5.5 (Abiomed, Inc), a surgically implanted endovascular microaxial left ventricular assist device, is increasingly used worldwide and there have been more than 10,000 implants.
Erin M. Schumer, MD, MPH, Yun Zhu Bai, MD, Kunal D. Kotkar, MD, M. Faraz Masood, MD, Akinobu Itoh, MD, PhD, Joel D. Schilling, MD, PhD, Gregory A. Ewald, MD, Marci S. Damiano, MSN, Irene Fischer, MPH, Tsuyoshi Kaneko, MD, Ralph J. Damiano, MD, Amit Pawale, MD   +11 more
doaj   +1 more source